Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Neoplasm
Clinical trial NCT03531918 · COMPLETED
Trial details
- NCT number
- NCT03531918
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-14
- Primary completion
- 2021-07-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.